Research field (2)：
Hygiene and public health (non-laboratory)
, Tumor diagnostics and therapeutics
Research keywords (2)：
甲状腺疾患
, 乳癌
Research theme for competitive and other funds (8)：
2022 - 2025 乳がん予防を目的とした身体活動基準の策定のための基盤研究
2022 - 2025 乳がん診断後のmodifiable life styleと乳がんアウトカム
2021 - 2024 Development of a risk tool for predicting chemo brain due to cancer treatment with new molecularly targeted therapy and chemotherapy in older patients
2018 - 2021 Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study
2015 - 2019 Establishment of evaluation methods for patient report outcome and quality of life
2015 - 2018 Breast cancer cohort study
2012 - 2015 Impact of modifiable lifestyle factors on outcomes after breast cancer diagnosis: the Setouchi Breast Cancer Cohort Study (SBCCS)
2008 - 2010 Identification of predictive factors of adjuvant chemotherapy for breast cancer
Show all
Papers (193)：
Shogo Nakamoto, Takayuki Iwamoto, Naruto Taira, Yukiko Kajiwara, Kengo Kawada, Daisuke Takabatake, Yuichiro Miyoshi, Shinichiro Kubo, Yoko Suzuki, Mari Yamamoto, et al. The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10. Breast cancer (Tokyo, Japan). 2024. 31. 5. 969-978
Masato Takahashi, Yuichiro Kikawa, Kosuke Kashiwabara, Naruto Taira, Tsuguo Iwatani, Kojiro Shimozuma, Shoichiro Ohtani, Tetsuhiro Yoshinami, Junichiro Watanabe, Masahiro Kashiwaba, et al. Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trial. EClinicalMedicine. 2024. 74. 102715-102715
Shogo Nakamoto, Yukiko Kajiwara, Kohei Taniguchi, Akira I Hida, Yuichiro Miyoshi, Takanori Kin, Mari Yamamoto, Daisuke Takabatake, Shinichiro Kubo, Hajime Hikino, et al. Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14. Breast cancer research and treatment. 2024
Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, et al. Correction: The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast cancer (Tokyo, Japan). 2024
Yutaka Yamamoto, Chikako Yamauchi, Tatsuya Toyama, Shigenori Nagai, Takehiko Sakai, Goro Kutomi, Michio Yoshimura, Masaaki Kawai, Shoichiro Ohtani, Kazunori Kubota, et al. The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment. Breast cancer (Tokyo, Japan). 2024. 31. 3. 340-346
